AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05800054 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: image-guided intensity-modulated radiotherapy (IGRT) or intensity-modulated radiotherapy (IMRT); Irradiation targets include primary lesions, clinical targets, positive lymph nodes, and lymph node drainage areas. Dose splitting/prescription dose, 95% volume PGTV-T60-66Gy/30-35 times, PGTV-N 60-66Gy/30-35 times, PCTV-T 46-50Gy/23-25 times, PCTV-N46-50Gy/23-25 times.
Study NCT06243133 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: clopidogrel for 90 days combined with aspirin for 90 days
Description: Clopidogrel 300mg on the first day, then 75mg/day for 90 consecutive days; Aspirin 100mg/day for 90 days
Study NCT06243133 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: clopidogrel for 30 days combined with aspirin for 90 days
Description: Clopidogrel 300mg on the first day, then 75mg/ day for 30 consecutive days; Aspirin 100mg/ day for 90 days
Study NCT06192602 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AIM_AT
Description: The program consists of 10 weekly/biweekly, 2-hour sessions (4-months), based on the modified Kemp's model/manual of Adherence therapy and mindfulness-based psychoeducation program developed by the research team.
Study NCT06192602 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CPG
Description: Psychoeducation group program (12-18 members/group) consists of 10 two-hour sessions, weekly/biweekly (similarly, 4-month duration) and is guided by a validated group-intervention protocol based on the research team's and McFarlane et al.'s psychoeducation programs for psychosis.
Study NCT06192602 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TAU
Description: Routine/Usual care only (control) group participants (and the two treatment groups) will receive usual community mental healthcare services.
Study NCT06192602 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TAU
Description: Routine/Usual care only (control) group participants (and the two treatment groups) will receive usual community mental healthcare services.
Study NCT06192602 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: TAU
Description: Routine/Usual care only (control) group participants (and the two treatment groups) will receive usual community mental healthcare services.
Study NCT06348511 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: XTics
Description: XTics is a gamified protocol of behavioral treatment for tic disorders. The participant's tics are monitored in real-time and they are reflected as achievements in a game that the participant plays at the same time. The rewards aim to counteract processes that consolidate the tic. XTics is compatible with ERP treatment, and it includes an introductory psychoeducation session and three behavioral training sessions.
Study NCT06348511 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: XTics
Description: XTics is a gamified protocol of behavioral treatment for tic disorders. The participant's tics are monitored in real-time and they are reflected as achievements in a game that the participant plays at the same time. The rewards aim to counteract processes that consolidate the tic. XTics is compatible with ERP treatment, and it includes an introductory psychoeducation session and three behavioral training sessions.
Study NCT04661865 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Health Information Package Program (HIP program )
Description: Fifteen minutes PowerPoint presentation will be introduced to women to increase women's educational experience and raise their level of engagement and commitment.~The principal investigator will narrate the video record with PowerPoint slides and it was recorded as a video and will include information regarding the introduction to pregnancy, causes and predisposing factors of iron deficiency anemia during pregnancy, signs and symptoms, prevention, management of iron deficiency anemia during pregnancy that includes iron therapy, iron supplementation, dietary management. Content validity for the information in the video will be done by sending it to three experts in maternity nursing. Iron supplementation will be given to all participants who will start by sixteen weeks of pregnancy and they will receive information regarding the proper usage of iron supplements.
Study NCT04661865 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Information Package Program (HIP program )
Description: Fifteen minutes PowerPoint presentation will be introduced to women to increase women's educational experience and raise their level of engagement and commitment.~The principal investigator will narrate the video record with PowerPoint slides and it was recorded as a video and will include information regarding the introduction to pregnancy, causes and predisposing factors of iron deficiency anemia during pregnancy, signs and symptoms, prevention, management of iron deficiency anemia during pregnancy that includes iron therapy, iron supplementation, dietary management. Content validity for the information in the video will be done by sending it to three experts in maternity nursing. Iron supplementation will be given to all participants who will start by sixteen weeks of pregnancy and they will receive information regarding the proper usage of iron supplements.
Study NCT05215509 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Supervised high-intensity interval training for 12 weeks three times per week. The supervision may be physical or online supervision
Study NCT05215509 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: No exercise
Description: Control group, therefore no supervised exercise regime
Study NCT05199649 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SintilimabCombined With Chemotherapy
Description: Sintilimab and chemotherapy are carried out at the same time for every 3 weeks
Study NCT05769348 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: HD-tDCS Active Protocol
Description: non-invasive brain stimulation (active protocol)
Study NCT05769348 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: HD-tDCS Sham Protocol
Description: non-invasive brain stimulation (sham protocol)
Study NCT05006261 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tele-Tai Chi
Description: 12-week simplified TC program using the Tele-TC platform at home, with recommended training sessions at least three times a week, and two or more supplementary live sessions.
Study NCT06360159 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention
Description: As an intervention, the newborn will be massaged.
Study NCT06008015 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR1015
Description: One tablet administered alone
Study NCT06008015 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BR1015-1
Description: One tablet administered alone
Study NCT06008015 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BR1015-2
Description: One tablet administered alone
Study NCT06082427 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality hypnosis
Description: VRH was delivered through a 3D virtual reality headpiece equipped with a head-tracking system based on hypnosis induction and suggestions (relaxation, comfort, and safety). The complete intervention lasted 17 minutes.
Study NCT06041100 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exoskeleton
Description: Use a passive assistive hip exoskeleton (alQ, Imasen Electrical Industrial Co., Ltd.) for 30 minutes daily during moderate to intensive activities over a period of 12-weeks. The exoskeleton is designed to aid hip flexion and as such its primary role is to improve gait by increasing step length and improving speed. The amount of time the exoskeleton has been used will be weekly monitored through phone calls and two gait sessions will be conducted to measure the development.
Study NCT05247606 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mobile application
Description: Lifestyle intervention through web-based mobile application
Study NCT06250972 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine, Nab-paclitaxel, Irinotecan
Description: continuing chemotherapy using the previous regimen until disease progression
Study NCT06250972 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiation Therapy (IMRT)
Description: Receive Intensity-Modulated Radiation Therapy (IMRT) after about 2\~6 cycles of chemotherapy.
Study NCT06250972 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Intensity-Modulated Radiation Therapy (IMRT)
Description: Receive Intensity-Modulated Radiation Therapy (IMRT) after about 2\~6 cycles of chemotherapy.
Study NCT05724615 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Outreach + Bulk ordering
Description: Participants will be sent an order for their lab screening and the recourse of the labs where they can schedule the screening.
Study NCT05724615 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Outreach + Bulk ordering + Text Based Reminders and Scheduling assistance
Description: Participants will be sent an order for their lab screening and the recourse of the labs where they can schedule the screening. They will also receive text messages to remind them to have their lab completed as well as a link to schedule the lab and inform them of walk-in hours.
Study NCT04712058 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bictegravir / Emtricitabine / Tenofovir Alafenamide Oral Tablet [Biktarvy]
Description: Biktarvy will be administered on the same day of diagnosis. The daily dosing will be continued for 48 weeks.
Study NCT05822388 — intervention group
Intervention type: PROCEDURE
Intervention: Deep Brain Stimulation Surgical Procedures as Part of Routine Clinical Care
Description: Participants in this study will already be undergoing a DBS intervention, however, this is part of their standard clinical care. Pre-surgical DBS candidates that enroll in this study will consent to participate in 1) pre-operative neuroimaging including a high-resolution MRI scan, 2) collection of pre-operative neurocognitive data via chart review and 3) a 1-year postoperative neurocognitive assessment.
Study NCT05993923 — intervention group
Intervention type: OTHER
Intervention: GPOU
Description: Intervention upstream of the perioperative management according to the nutritional grade. Grade 4 Nutrition patients will be hospitalized earlier, i.e. 10 to 15 days before surgery for the start of artificial nutrition. A temporary return home can be organized with the supervision of a service provider until a second admission for surgical management. Grade 2 Nutrition patients will be called 24 to 48 hours before the surgical procedure.~Anticipation of discharge at admittance Early mobilization Comorbidity management Prevention of iatrogenia Management of geriatric frailties Daily medical and paramedical assessment Detailed discharge report
Study NCT04891289 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine
Description: See arm for details.
Study NCT04891289 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: See arm for details.
Study NCT04891289 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxaliplatin
Description: See arm for details.
Study NCT04891289 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: See arm for details.
Study NCT04891289 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: See arm for details.
Study NCT04891289 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Floxuridine (FUDR)
Description: See arm for details.
Study NCT04891289 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Implanted Medical Device
Description: Implanted hepatic arterial infusion pump by surgical oncology, to deliver HAI therapy
Study NCT06542666 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive Functional Therapy
Description: The intervention focuses on addressing the maladaptive cognitive, physical, and lifestyle behaviors related to the disorder.~Cognitive functional therapy will focus on factors considered to contribute to the pain disorder, addressing the following topics:~1. The multidimensional nature of persistent pain, beliefs, emotions, and behaviors (movement and lifestyle) that can reinforce a vicious cycle of pain sensitization and disability.~2. Specific functional training designed to normalize maladaptive and provocative postural and movement behaviors as directed by the individual's presentation.~3. Targeted functional integration into daily activities that are avoided and/or provocative for the patient.~4. Counseling on physical activity and lifestyle, which will include promoting a gradual increase in physical activity based on the individual's preference and availability, advice on sleep hygiene, stress management strategies, and social re-engagement
Study NCT06542666 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercises
Description: Individuals allocated to this group will perform stretching and strengthening exercises. The self-stretching exercises will target the upper trapezius and posterior shoulder region. Each stretching exercise will be performed for 3 repetitions of 30 seconds, with an interval of 10 seconds between repetitions.~The strengthening exercises will be performed using resistance elastic bands. Three sets of 10 repetitions will be performed for each strengthening exercise, with 1 minute of rest between sets. The strengthening exercises will target the lower and middle trapezius, anterior serratus, and the external and internal rotators of the shoulder.
Study NCT05700877 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CAC-based treatment strategy
Description: The intervention is a combination of screening with a heart CT scan and multifactorial intervention based on the screening results. Participants randomized to CAC-based treatment and with screening results showing high risk of CVD, will receive a multifactorial intervention including the combination of two open label investigational medical products: dapagliflozin 10mg/day and semaglutide 0.25 /week or 0.5 /week or 1.0 /week.
Study NCT05700877 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard treatment
Description: Participants randomized to standard treatment are recommended to follow updated guidelines for CVD prevention.
Study NCT06540430 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Use of a Mobile Application for Stoma Self-Care
Description: The intervention group will use a mobile application where patients input their stoma condition, allowing healthcare professionals to monitor and manage their care. The app provides patients with information on diet, physical activity, stoma care, emotional support, and daily living needs.
Study NCT05524779 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BTL-785-7
Description: Treatment with the BTL-785-7 applicator to the BTL-785F system.
Study NCT04757402 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Counselling with NSQIP Surgical risk calculator
Description: Use of NSQIP surgical risk calculator to check for patient satisfaction regarding pre operative counseling.
Study NCT04757402 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Counselling with NSQIP Surgical risk calculator
Description: Use of NSQIP surgical risk calculator to check for patient satisfaction regarding pre operative counseling.
Study NCT05943886 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC88473 injection
Description: HEC88473 will be provided as a 17 mg/mL solution and will be administered by subcutaneous injection in the abdomen.
Study NCT06631235 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: orthopedic appliance
Description: appliances are used to correct skeletal class II due to mandibular deficiency
Study NCT06631235 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aesthetic orthopedic appliance
Description: aesthetic appliances are used to correct skeletal class II due to mandibular deficiency
Study NCT06213961 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pecha kucha education
Description: Basic life support training to be given to students will be given by the pecha kucha presentation method.
Study NCT06330506 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pressure ulcer prevention pack
Description: The pressure ulcer prevention package to be prepared by the researchers will be applied
Study NCT05943886 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered by subcutaneous injection in the abdomen.
Study NCT06554379 — intervention group
Intervention type: OTHER
Intervention: Periodontal health and gingivitis
Description: The presence or absence of periodontal disease in the gingiva was determined.
Study NCT04756466 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Each participant will consume 1 capsule per day in one of the main meals without any restriction in the diet or in their life habits
Study NCT05069012 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine Sulfate
Description: Morphine is administered to provide pain relief after cesarean delivery; this is an assessment of the dose-response as measured by the duration of pain relief
Study NCT04756466 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus
Description: Each participant will consume 1 capsule per day in one of the main meals without any restriction in the diet or in their life habits
Study NCT05244746 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: rectus sheath block
Description: blocking the nerve underneath the rectus muscle by bupivicaine
Study NCT05244746 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: rectus sheath block
Description: blocking the nerve underneath the rectus muscle by bupivicaine
Study NCT04761133 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Povidone-Iodine pleural irrigation
Description: Irrigation of the infected pleural cavity with an antiseptic solution to reduce microbial load
Study NCT04851509 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dynamic Rotational Locking
Description: Performed, as per the Synthes technique guide, using the 5mm hex flexible set screwdriver and then loosening the set screw by one-half turn of the screwdriver.
Study NCT01108913 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bimosiamose
Study NCT01108913 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT04851509 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Static Locking
Description: Performed by using the torque-limiting set screwdriver and locking the set screw down onto the helical screw to prevent dynamic sliding of the screw within the nail.
Study NCT06555952 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MegaNatural-BP SR 150Mg Tablet
Description: GSE MegaNatural BP
Study NCT06555952 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Capsule
Description: given in place of GSE MegaNatural BP
Study NCT05163548 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PerQseal Plus Device
Description: Percutaneous closure of femoral artery access site created by 14 to 22 F sheaths (up to 26 F arteriotomy) in patients undergoing Percutaneous Transcatheter procedures.
Study NCT05248919 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epclusa (nucleotide HCV NS5B polymerase inhibitors).
Description: Sofosbuvir (400mg/day) and Velpatasvir(100mg/day) for 12 weeks or 24 weeks
Study NCT04516356 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Korean hand acupressure
Description: According to the working principle of Korean hand acupressure; There are active points and areas in the hands and feet that fit the whole body. The active points on the hands and feet are properly matched to reflect the anatomy of the whole organism. Areas in the body and systems suitable for them are in constant contact. In the patient, the signal wave moves from the damaged point or area and reaches the appropriate point immediately. Thus, changes such as severe pain, skin discoloration, hardening, thickening and thinning in some parts of the skin occur at that point. With the stimulation of the effective point, a treatment wave occurs that heals the sick organ.
Study NCT05053594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neostigmine 10 mcg/kg
Description: Once the third response to TOF is obtained, neostigmine 10 mcg/kg will be administered
Study NCT05053594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neostigmine 20 mcg/kg
Description: Once the third response to TOF is obtained, neostigmine 20 mcg/kg will be administered
Study NCT05053594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neostigmine 30 mcg/kg
Description: Once the third response to TOF is obtained, neostigmine 30 mcg/kg will be administered
Study NCT05053594 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Once the third response to TOF is obtained, saline will be administered
Study NCT04824612 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Photobiomodulation with blue led
Description: Preoperative: every two weeks for 30 days. Postoperative: Immediately after surgery, weekly for 4 weeks, every two weeks for another 4 weeks, and one session in 3rd month. blue LED (470 nm, 0,4W, 24J per point on 10 linear points, total 240J).